Published Date：Jan. 2021
Industry：Medical Devices & Consumables
Pages：103 Table Number：124
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Super Generics market in this environment. In terms of revenue, this research report indicated that the global Super Generics market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Super Generics industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The Sun Pharmaceutical Industries aims at producing XX Super Generics in 2020, with XX % production to take place in global market, Meda Pharmaceuticals accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Super Generics Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Super Generics Market? Sun Pharmaceutical Industries Meda Pharmaceuticals Taiwan Liposome Company Dr. Reddy’s Laboratories Allergan Teva Pharmaceutical Industries Celgene Corporation ... Major Type of Super Generics Covered in XYZResearch report: Drugs Biologics Application Segments Covered in XYZResearch Market Hospital Pharmacies Retail Pharmacies Online Pharmacies Drug Stores For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Super Generics Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Drugs -Product Introduction and Major Manufacturers 1.1.2 Biologics -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Super Generics Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026) 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026) 3 Regional Market Analysis 3.1 China Super Generics Market 3.1.1 Top Companies leading Super Generics Development in China (2015-2020) 3.1.2 Sales Value of Major Company in China Market (2015-2020) 3.1.3 China Super Generics Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2015-2026) 3.2 EU Super Generics Market 3.2.1 Top Companies leading Super Generics Development in EU (2015-2020) 3.2.2 Sales Value of Major Company in EU Market (2015-2020) 3.2.3 EU Super Generics Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2015-2026) 3.3 USA Super Generics Market 3.3.1 Top Companies leading Super Generics Development in USA (2015-2020) 3.3.2 Sales Value of Major Company in USA Market (2015-2020) 3.3.3 USA Super Generics Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2015-2026) 3.4 Japan Super Generics Market 3.4.1 Top Companies leading Super Generics Development in Japan (2015-2020) 3.4.2 Sales Value of Major Company in Japan Market (2015-2020) 3.4.3 Japan Super Generics Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2015-2026) 3.5 India Super Generics Market 3.5.1 Top Companies leading Super Generics Development in India (2015-2020) 3.5.2 Sales Value of Major Company in India Market (2015-2020) 3.5.3 India Super Generics Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2015-2026) 3.6 Southeast Asia Super Generics Market 3.6.1 Top Companies leading Super Generics Development in Southeast Asia (2015-2020) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020) 3.6.3 Southeast Asia Super Generics Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026) 3.7 South America Super Generics Market 3.7.1 Top Companies leading Super Generics Development in South America (2015-2020) 3.7.2 Sales Value of Major Company in South America Market (2015-2020) 3.7.3 South America Super Generics Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2015-2026) 4 Value Chain (Impact of COVID-19) 4.1 Super Generics Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Super Generics Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2026) 5.1 Global Super Generics Sales and Growth Rate (2021-2026) 5.2 Global Super Generics Sales Value and Growth Rate (2021-2026) 6 Super Generics Competitive Analysis 6.1 Sun Pharmaceutical Industries 6.1.1 Sun Pharmaceutical Industries Company Profiles 6.1.2 Sun Pharmaceutical Industries Product Introduction 6.1.3 Sun Pharmaceutical Industries Super Generics Production, Revenue (2015-2020) 6.1.4 SWOT Analysis 6.2 Meda Pharmaceuticals 6.2.1 Meda Pharmaceuticals Company Profiles 6.2.2 Meda Pharmaceuticals Product Introduction 6.2.3 Meda Pharmaceuticals Super Generics Production, Revenue (2015-2020) 6.2.4 SWOT Analysis 6.3 Taiwan Liposome Company 6.3.1 Taiwan Liposome Company Company Profiles 6.3.2 Taiwan Liposome Company Product Introduction 6.3.3 Taiwan Liposome Company Super Generics Production, Revenue (2015-2020) 6.3.4 SWOT Analysis 6.4 Dr. Reddy’s Laboratories 6.4.1 Dr. Reddy’s Laboratories Company Profiles 6.4.2 Dr. Reddy’s Laboratories Product Introduction 6.4.3 Dr. Reddy’s Laboratories Super Generics Production, Revenue (2015-2020) 6.4.4 SWOT Analysis 6.5 Allergan 6.5.1 Allergan Company Profiles 6.5.2 Allergan Product Introduction 6.5.3 Allergan Super Generics Production, Revenue (2015-2020) 6.5.4 SWOT Analysis 6.6 Teva Pharmaceutical Industries 6.6.1 Teva Pharmaceutical Industries Company Profiles 6.6.2 Teva Pharmaceutical Industries Product Introduction 6.6.3 Teva Pharmaceutical Industries Super Generics Production, Revenue (2015-2020) 6.6.4 SWOT Analysis 6.7 Celgene Corporation 6.7.1 Celgene Corporation Company Profiles 6.7.2 Celgene Corporation Product Introduction 6.7.3 Celgene Corporation Super Generics Production, Revenue (2015-2020) 6.7.4 SWOT Analysis 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020) Figure Global Super Generics Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2026) Table CAGR in Terms of Production of Each Type (2015-2026) Table CAGR in Terms of Production of Each Application (2015-2026) Table Global Super Generics Sales (K Unit) by Type (2015-2026) Figure Global Super Generics Sales (K Unit) and Growth Rate (2015-2026) Figure Global Super Generics Sales Market Share (%) by Type (2019 -2020) Table Global Super Generics Sales Value (Million USD) by Type (2015-2026) Figure Global Super Generics Sales Value (Million USD) and Growth Rate (2015-2026) Figure Global Super Generics Sales Value Market Share (%) by Type (2019-2020) Table Global Super Generics Sales (K Unit) by Application (2015-2026) Table China Super Generics Sales (K Unit) of Major Company (2015-2020) Table China Super Generics Sales Market Share of Major Company (2015-2020) Table China Super Generics Sales Value (Million USD) of Major Company (2015-2020) Figure China Super Generics Sales Value (Million USD) and Growth Rate (2015-2020) Table China Super Generics Sales Value Share of Major Company (2015-2020) Table China Super Generics Price (USD/Unit), by Type (2019-2020) Table China Super Generics Sales (Unit) by Type (2015-2026) Figure China Super Generics Sales (Unit) by Type (2015-2026) Table EU Super Generics Sales (K Unit) of Major Company (2015-2020) Table EU Super Generics Sales Market Share of Major Company (2015-2020) Table EU Super Generics Sales Value (Million USD) of Major Company (2015-2020) Figure EU Super Generics Sales Value (Million USD) and Growth Rate (2015-2020) Table EU Super Generics Sales Value Share of Major Company (2015-2020) Table EU Super Generics Price (USD/Unit), by Type (2019-2020) Table EU Super Generics Sales (Unit) by Type (2015-2026) Figure EU Super Generics Sales (Unit) by Type (2015-2026) Table USA Super Generics Sales (K Unit) of Major Company (2015-2020) Table USA Super Generics Sales Market Share of Major Company (2015-2020) Table USA Super Generics Sales Value (Million USD) of Major Company (2015-2020) Figure USA Super Generics Sales Value (Million USD) and Growth Rate (2015-2020) Table USA Super Generics Sales Value Share of Major Company (2015-2020) Table USA Super Generics Price (USD/Unit), by Type (2019-2020) Table USA Super Generics Sales (Unit) by Type (2015-2026) Figure USA Super Generics Sales (Unit) by Type (2015-2026) Table Japan Super Generics Sales (K Unit) of Major Company (2015-2020) Table Japan Super Generics Sales Market Share of Major Company (2015-2020) Table Japan Super Generics Sales Value (Million USD) of Major Company (2015-2020) Figure Japan Super Generics Sales Value (Million USD) and Growth Rate (2015-2020) Table Japan Super Generics Sales Value Share of Major Company (2015-2020) Table Japan Super Generics Price (USD/Unit), by Type (2019-2020) Table Japan Super Generics Sales (Unit) by Type (2015-2026) Figure Japan Super Generics Sales (Unit) by Type (2015-2026) Table India Super Generics Sales (K Unit) of Major Company (2015-2020) Table India Super Generics Sales Market Share of Major Company (2015-2020) Table India Super Generics Sales Value (Million USD) of Major Company (2015-2020) Figure India Super Generics Sales Value (Million USD) and Growth Rate (2015-2020) Table India Super Generics Sales Value Share of Major Company (2015-2020) Table India Super Generics Price (USD/Unit), by Type (2019-2020) Table India Super Generics Sales (Unit) by Type (2015-2026) Figure India Super Generics Sales (Unit) by Type (2015-2026) Table Southeast Asia Super Generics Sales (K Unit) of Major Company (2015-2020) Table Southeast Asia Super Generics Sales Market Share of Major Company (2015-2020) Table Southeast Asia Super Generics Sales Value (Million USD) of Major Company (2015-2020) Figure Southeast Asia Super Generics Sales Value (Million USD) and Growth Rate (2015-2020) Table Southeast Asia Super Generics Sales Value Share of Major Company (2015-2020) Table Southeast Asia Super Generics Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Super Generics Sales (Unit) by Type (2015-2026) Figure Southeast Asia Super Generics Sales (Unit) by Type (2015-2026) Table South America Super Generics Sales (K Unit) of Major Company (2015-2020) Table South America Super Generics Sales Market Share of Major Company (2015-2020) Table South America Super Generics Sales Value (Million USD) of Major Company (2015-2020) Figure South America Super Generics Sales Value (Million USD) and Growth Rate (2015-2020) Table South America Super Generics Sales Value Share of Major Company (2015-2020) Table South America Super Generics Price (USD/Unit), by Type (2019-2020) Table South America Super Generics Sales (Unit) by Type (2015-2026) Figure South America Super Generics Sales (Unit) by Type (2015-2026) Figure Value Chain Structure of Super Generics Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Super Generics Figure Cost Structure of Super Generics in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2026) Table Regional Market Sales Share (2021-2026) Figure Global Super Generics Sales (Unit), Growth Rate & Market Share (2021-2026) Table Regional Market Sales Value (Million USD) (2021-2026) Table Regional Market Sales Value Share (2021-2026) Figure Global Super Generics Sales Value (Million USD), Growth Rate & Market Share (2021-2026) Table Sun Pharmaceutical Industries Profiles Table Sun Pharmaceutical Industries Super Generics Product Introduction Table Sun Pharmaceutical Industries Super Generics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Sun Pharmaceutical Industries SWOT Analysis Table Meda Pharmaceuticals Profiles Table Meda Pharmaceuticals Super Generics Product Introduction Table Meda Pharmaceuticals Super Generics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Meda Pharmaceuticals SWOT Analysis Table Taiwan Liposome Company Profiles Table Taiwan Liposome Company Super Generics Product Introduction Table Taiwan Liposome Company Super Generics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Taiwan Liposome Company SWOT Analysis Table Dr. Reddy’s Laboratories Profiles Table Dr. Reddy’s Laboratories Super Generics Product Introduction Table Dr. Reddy’s Laboratories Super Generics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Dr. Reddy’s Laboratories SWOT Analysis Table Allergan Profiles Table Allergan Super Generics Product Introduction Table Allergan Super Generics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Allergan SWOT Analysis Table Teva Pharmaceutical Industries Profiles Table Teva Pharmaceutical Industries Super Generics Product Introduction Table Teva Pharmaceutical Industries Super Generics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Teva Pharmaceutical Industries SWOT Analysis Table Celgene Corporation Profiles Table Celgene Corporation Super Generics Product Introduction Table Celgene Corporation Super Generics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
